E-LIB Suche - Ergebnisse für: Prat, A

1

Dark Energy Survey Year 3 results: Simulation-based cosmolo..:

Gatti, M. ; Jeffrey, N. ; Whiteway, L....
Physical Review D. 109 (2024) 6 - p. , 2024

Link: https://doi.org/10.1103/..

2

13P HER2DX ERBB2 mRNA score in first-line metastatic HER2-p..:

Bayona, R. Sanchez ; Martínez-Sáez, O. ; Romero, D.R....
ESMO Open. 9 (2024) - p. 103022 , 2024

Link: https://doi.org/10.1016/..

3

163P Characterization of HER2-low breast cancer in young wo..:

Schettini, F. ; Blondeaux, E. ; Molinelli, C....
ESMO Open. 9 (2024) - p. 103185 , 2024

Link: https://doi.org/10.1016/..

4

213P Sequencing antibody-drug conjugates (ADCs) in patients..:

Morganti, S. ; Tarantino, P. ; Graham, N....
ESMO Open. 9 (2024) - p. 103235 , 2024

Link: https://doi.org/10.1016/..

5

16P Determinants of response to short preoperative endocrin..:

Bravo, R. Gómez ; Walbaum, B. ; Schettini, F....
ESMO Open. 9 (2024) - p. 103024 , 2024

Link: https://doi.org/10.1016/..

6

487P HER2DX ERBB2 mRNA assay following trastuzumab-based ch..:

Sauri Nadal, T. ; Pesantez Coronel, D.S. ; Braso Maristany, F....
Annals of Oncology. 35 (2024) - p. S194 , 2024

Link: https://doi.org/10.1016/..

7

1MO HER2DX assay and survival outcomes: An individual-patie..:

Javierre, G. Villacampa ; Cortés, J. ; García, J.M. Pérez...
ESMO Open. 9 (2024) - p. 103011 , 2024

Link: https://doi.org/10.1016/..

8

Unraveling the clinicopathological and molecular changes in..:

Schettini, F. ; Nucera, S. ; Brasó-Maristany, F....
ESMO Open. 9 (2024) 7 - p. 103619 , 2024

Link: https://doi.org/10.1016/..

9

199P Adoptive PD1+ tumor-infiltrating lymphocyte therapy fo..:

Angelats, L. ; Eslava, M. Santisteban ; Manich, C. Saura...
ESMO Open. 9 (2024) - p. 103221 , 2024

Link: https://doi.org/10.1016/..

10

49P A ctDNA tool for identifying ESR1-mutated biology in ES..:

Fructuoso, I. Garcia ; Martínez-Sáez, O. ; Pardo, F....
ESMO Open. 9 (2024) - p. 103056 , 2024

Link: https://doi.org/10.1016/..

11

22P Unveiling biological and prognostic differences among p..:

Walbaum, B. ; Chic, N. ; Bruñol, C. Crous...
ESMO Open. 9 (2024) - p. 103030 , 2024

Link: https://doi.org/10.1016/..

12

Anémies hémolytiques auto-immunes à anticorps chauds associ..:

Colbert, J. ; Moulis, G. ; Zhao, L.P....
La Revue de Médecine Interne. 45 (2024) - p. A72 , 2024

Link: https://doi.org/10.1016/..

13

Prognostic value of HER2DX in early-stage HER2-positive bre..:

Villacampa, G. ; Pascual, T. ; Brasó-Maristany, F....
ESMO Open. 9 (2024) 3 - p. 102388 , 2024

Link: https://doi.org/10.1016/..

14

182MO Trastuzumab deruxtecan (T-DXd) vs treatment of physic..:

Kim, S-B. ; André, F. ; Takano, T....
ESMO Open. 9 (2024) - p. 103204 , 2024

Link: https://doi.org/10.1016/..

15

10P PIK3CA mutation and response to neoadjuvant taselisib a..:

Fimereli, D. ; Nuciforo, P.G. ; de Azambuja, E....
ESMO Open. 9 (2024) - p. 103019 , 2024

Link: https://doi.org/10.1016/..